News | September 20, 2010

Robotic Cath Lab Navigation System to be Presented at TCT

September 20, 2010 - Results for the first-in-human study for a robotic cath lab navigation system will be announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference. Corindus Vascular Robotics will present information on the study involving its CorPath 200 System.

The study, performed at the Corbic Research Institute in Envigado, Colombia, was conducted on eight patients to evaluate the safety and technical efficacy of the system in delivering and manipulating coronary guidewires and stent/balloon systems in PCI procedures. Juan F. Granada, M.D., medical director, Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation (CRF), was the principal investigator of the study. Juan Andreas Delgado, M.D., and Giora Weiszm, M.D., also participated in the study.

“The trial reached its primary endpoint of zero MACE at 48 hours,” Granada said. “I was impressed by the CorPath 200 System’s ability to precisely control and deliver the guidewire and other angioplasty devices to the target lesion. It definitely helped to perform the procedure in a highly controlled manner. Conducting the procedure while sitting in the system’s cockpit gave me more control and better focus on my patient than I would have achieved standing alongside the procedure table.”

“The procedure time, including setup and patient turnover, was similar to conventional manual operation, which is impressive considering this was the first time we used the CorPath 200 System at my center," Delgado said. All eight patients in the study were discharged with less than 30 percent stenosis following their procedures, and a 30-day follow-up was completed without occurrence of MACE.

According to Weisz, the system represents a paradigm shift in the control of PCI procedures and a major step toward a healthier and safer environment for physicians who spend increasingly longer hours in cath labs.

“The CorPath 200 System allows me to perform a PCI procedure while sitting comfortably in the interventional cockpit without the strain of a heavy lead apron,” Weisz said, adding that his exposure to radiation dropped drastically. “During the study, my mean radiation exposure without a lead apron was only 1.81 µGy. That is 97 percent less than I would have received had I worn an apron and performed the same procedures manually. The system was also very intuitive and easy to use.”

To make an appointment for an individual hands-on demonstration of the CorPath 200 System at TCT 2010, call 1-508-653-3335 x213, or email [email protected]

For more information please visit:

Related Content

Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Videos | Chronic Total Occlusion (CTO)| September 28, 2017
Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital, discusses the newes
Overlay Init